ANTIATHEROSCLEROTIC EFFECTS OF ANTIOXIDANTS ARE LESION-SPECIFIC WHEN EVALUATED IN HYPERCHOLESTEROLEMIC NEW-ZEALAND WHITE-RABBITS

被引:36
作者
BOCAN, TMA
MUELLER, SB
BROWN, EQ
UHLENDORF, PD
MAZUR, MJ
NEWTON, RS
机构
[1] Department of Pharmacology, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, MI 48105
关键词
D O I
10.1016/0014-4800(92)90050-L
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Oxidative modification of LDL may represent an initiating event in the formation of monocyte-macrophage foam cells, a major cell present in fatty streaks and atherosclerotic fibrous plaques. Therefore, we studied the effect of such antioxidants as probucol (500 mg/kg) and vitamins E and C (500 mg/kg each) on the regression of induced iliac-femoral lesions and progression of naturally occurring thoracic aortic fatty streak lesions in hypercholesterolemic New Zealand White rabbits. Following an initial 9-week lesion induction phase, both therapies were evaluated for 8 weeks. Probucol lowered plasma cholesterol 47% while vitamins E and C had no effect on plasma cholesterol. Probucol decreased the cholesteryl ester (CE) content of the thoracic aorta by 31% without changing the thoracic aortic lesion coverage. Vitamins E and C decreased thoracic aortic CE content by 40% and lesion coverage by 46%. Neither probucol nor vitamins E and C altered the CE content, lesion size, or macrophage/lesion ratio of the iliac-femoral artery. Thus, we conclude that the effects of antioxidants are specific to the stage of atherosclerotic lesion development. Antioxidant therapy alters the progression and cholesteryl ester enrichment of diet-induced thoracic aortic fatty streaks but has no effect on the progression and/or regression of more complicated injury-induced iliac-femoral lesions. © 1992.
引用
收藏
页码:70 / 83
页数:14
相关论文
共 38 条
[1]  
ALLAIN CC, 1974, CLIN CHEM, V20, P470
[2]   THE ANTIOXIDANT BUTYLATED HYDROXYTOLUENE PROTECTS AGAINST ATHEROSCLEROSIS [J].
BJORKHEM, I ;
HENRIKSSONFREYSCHUSS, A ;
BREUER, O ;
DICZFALUSY, U ;
BERGLUND, L ;
HENRIKSSON, P .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :15-22
[3]  
BOCAN TMA, 1986, AM J PATHOL, V123, P413
[4]   COMPARISON OF CI-976, AN ACAT INHIBITOR, AND SELECTED LIPID-LOWERING AGENTS FOR ANTIATHEROSCLEROTIC ACTIVITY IN ILIAC FEMORAL AND THORACIC AORTIC LESIONS - A BIOCHEMICAL, MORPHOLOGICAL, AND MORPHOMETRIC EVALUATION [J].
BOCAN, TMA ;
MUELLER, SB ;
UHLENDORF, PD ;
NEWTON, RS ;
KRAUSE, BR .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (06) :1830-1843
[5]   HUMAN AORTIC FIBROLIPID LESIONS - IMMUNOCHEMICAL LOCALIZATION OF APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A [J].
BOCAN, TMA ;
BROWN, SA ;
GUYTON, JR .
ARTERIOSCLEROSIS, 1988, 8 (05) :499-508
[6]   DIETARY AND MECHANICALLY INDUCED RABBIT ILIAC FEMORAL ATHEROSCLEROTIC LESIONS - A CHEMICAL AND MORPHOLOGICAL EVALUATION [J].
BOCAN, TMA ;
MUELLER, SB ;
UHLENDORF, PD ;
FERGUSON, E ;
NEWTON, RS .
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 1991, 54 (03) :201-217
[7]  
BOYD HC, 1989, AM J PATHOL, V135, P815
[8]   ACTIONS OF VITAMINS-A AND VITAMIN-E AND SOME NICOTINIC-ACID DERIVATIVES ON PLASMA-LIPIDS AND ON LIPID INFILTRATION OF AORTA IN CHOLESTEROL-FED RABBITS [J].
BRATTSAND, R .
ATHEROSCLEROSIS, 1975, 22 (01) :47-61
[9]   PROBUCOL - A REAPPRAISAL OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN HYPERCHOLESTEROLEMIA [J].
BUCKLEY, MMT ;
GOA, KL ;
PRICE, AH ;
BROGDEN, RN .
DRUGS, 1989, 37 (06) :761-800
[10]  
BUCOLO G, 1973, CLIN CHEM, V19, P476